A single step mouth cancer diagnostic that can be moulded into a solid and applied lollipop-style has won backing from Cancer Research UK and the Physic.
Personalis Launches NeXT Personal® Dx for Early Access Clinical Use in Residual Disease and Recurrence Detection in Cancer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Personalis (PSNL) Launches NeXT Personal Dx for Early Access Clinical Use streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
NeXT Personal® ctDNA assay shown to be more sensitive and predictive of clinical outcomes in early-stage lung cancer patients
Demonstrates importance of an ultra-sensitive ctDNA approach
.
Personalis, Inc. announced the presentation of initial findings from its work with the TRACERx lung cancer study, marking a substantial advancement in lung cancer circulating tumor DNA detection and.